Increased incidence of intracranial complications following pediatric sinogenic and otogenic infections in the post-COVID-19 Era: A systematic review and meta-analysis

Background

This systematic-review and meta-analysis aims to evaluate and summarize the prevalence of pediatric intracranial complications following sinogenic or otogenic infections before and after the COVID-19 pandemic.

Methods

A literature search was performed using the PubMed, Scopus, and CINAHL databases to answer the question: In pediatric patients, was there an increase in the prevalence or severity of intracranial complications due to sinogenic or otogenic infections during and after the COVID-19 pandemic? Publications which included primary data on patients under the age of 18 years old, focusing on intracranial complications following otogenic and sinogenic infections were included.

Results

Of 1025 abstracts screened, 18 studies were included. There were no significant differences in age or sex between the two cohorts. Compared to the pre-COVID era, post-COVID infections were more likely to have neurologic complications upon presentation [11.4 % (1.6–53.0) vs 50.1 % (13.9–86.2), p < 0.01], cerebral venous sinus thrombosis (CVST) [14.1 % (10.6–18.2) vs 40.5 % (25.2–56.9), p < 0.01], intraparenchymal abscess [40.3 % (43.9–72.2) vs 54.9 % (25.2–87.1), p < 0.01], and meningitis [10.6 % (0.0–39.4) vs 40.2 % (13.4–70.8), p < 0.01]. Metronidazole use [38.7 % (31.8–46.0) vs 71.9 % (51.3–88.6), p < 0.01], craniectomy [16.1 % (1.3–42.8) vs 37.4 % (2.9–83.0), p = 0.02], and burr holes [16.8 % (11.5–23.3) vs 26.6 % (12.7–43.3), p = 0.02] were increased in the post-COVID cohort.

Conclusion

There are considerable differences in neurologic deficits, CVST, intraparenchymal abscesses, meningitis, and treatment modalities in pre- and post-COVID cohorts of children with intracranial complications of otorhinogenic origin. Further research is required to determine the underlying mechanism for these differences.